Neuromod Devices
Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.
Neuromod Devices is a business in biotechnology, clinical trials, health care, medical, medical device based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2010.
The company sits in the biotechnology, clinical trials, health care, medical, medical device segment, where it competes on its core product or service.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
The company is listed at the Debt_Financing stage of development.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $55.5M.
| Sector | Biotechnology, Clinical Trials, Health Care, Medical, Medical Device |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2010 |
| Employees | c_00011_00050 |
| Stage | debt_financing |
| Total funding | $55,500,000 |
Website: neuromoddevices.com
Browse related
Create a free account